Parmacek MS - Search Results

1

SM22alpha promoter targets gene expression to vascular smooth muscle cells in vitro and in vivo.

Akyürek LM, Yang ZY, Aoki K, San H, Nabel GJ, Parmacek MS, Nabel EG. Akyürek LM, et al. Among authors: parmacek ms. Mol Med. 2000 Nov;6(11):983-91. Mol Med. 2000. PMID: 11147575 Free PMC article.

2

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy.

Aoki K, Akyürek LM, San H, Leung K, Parmacek MS, Nabel EG, Nabel GJ. Aoki K, et al. Among authors: parmacek ms. Mol Ther. 2000 Jun;1(6):555-65. doi: 10.1006/mthe.2000.0076. Mol Ther. 2000. PMID: 10933980 Free article.

3

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product.

Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Chang MW, et al. Among authors: parmacek ms. Science. 1995 Jan 27;267(5197):518-22. doi: 10.1126/science.7824950. Science. 1995. PMID: 7824950

4

Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function.

Zhang JC, Kim S, Helmke BP, Yu WW, Du KL, Lu MM, Strobeck M, Yu Q, Parmacek MS. Zhang JC, et al. Among authors: parmacek ms. Mol Cell Biol. 2001 Feb;21(4):1336-44. doi: 10.1128/MCB.2001.21.4.1336-1344.2001. Mol Cell Biol. 2001. PMID: 11158319 Free PMC article.

5

Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells.

Strobeck M, Kim S, Zhang JC, Clendenin C, Du KL, Parmacek MS. Strobeck M, et al. Among authors: parmacek ms. J Biol Chem. 2001 May 11;276(19):16418-24. doi: 10.1074/jbc.M100631200. Epub 2001 Feb 8. J Biol Chem. 2001. PMID: 11279108 Free article.

6

Ablation of SM22alpha decreases contractility and actin contents of mouse vascular smooth muscle.

Zeidan A, Swärd K, Nordström I, Ekblad E, Zhang JC, Parmacek MS, Hellstrand P. Zeidan A, et al. Among authors: parmacek ms. FEBS Lett. 2004 Mar 26;562(1-3):141-6. doi: 10.1016/S0014-5793(04)00220-0. FEBS Lett. 2004. PMID: 15044015 Free article.

7

Structure and expression of a smooth muscle cell-specific gene, SM22 alpha.

Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, Morrisey EE, Ip HS, Parmacek MS. Solway J, et al. Among authors: parmacek ms. J Biol Chem. 1995 Jun 2;270(22):13460-9. doi: 10.1074/jbc.270.22.13460. J Biol Chem. 1995. PMID: 7768949 Free article.

8

An essential role for connexin43 gap junctions in mouse coronary artery development.

Li WE, Waldo K, Linask KL, Chen T, Wessels A, Parmacek MS, Kirby ML, Lo CW. Li WE, et al. Among authors: parmacek ms. Development. 2002 Apr;129(8):2031-42. doi: 10.1242/dev.129.8.2031. Development. 2002. PMID: 11934868

9

High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice.

Lepore JJ, Cheng L, Min Lu M, Mericko PA, Morrisey EE, Parmacek MS. Lepore JJ, et al. Among authors: parmacek ms. Genesis. 2005 Apr;41(4):179-84. doi: 10.1002/gene.20112. Genesis. 2005. PMID: 15789423

10

A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages.

Kim S, Ip HS, Lu MM, Clendenin C, Parmacek MS. Kim S, et al. Among authors: parmacek ms. Mol Cell Biol. 1997 Apr;17(4):2266-78. doi: 10.1128/MCB.17.4.2266. Mol Cell Biol. 1997. PMID: 9121477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters